Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Parabilis Medicines, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Parabilis Medicines, Inc.Listing unverified | Other | $5M | SEC | ||
Parabilis Medicines, Inc.Listing unverified | Buy | $2.5M | conv 65ClusterFirst in 12mo | SEC | |
Parabilis Medicines, Inc.Listing unverified | Buy | $7.5M | conv 75ClusterFirst in 12mo | SEC | |
BioAtla, Inc.Listing on record | Award | $7.5M | SEC | ||
BioAtla, Inc.Listing on record | Sell | $8.2M | SEC | ||
BioAtla, Inc.Listing on record | Sell | $2.1M | SEC | ||
BioAtla, Inc.Listing on record | Sell | $11.3M | SEC | ||
BioAtla, Inc.Listing on record | Sell | $13.2M | SEC | ||
BioAtla, Inc.Listing on record | Sell | $2.5M | SEC | ||
BioAtla, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
BioAtla, Inc.Listing on record | Buy | $19M | conv 32First in 12mo | SEC | |
BioAtla, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
BioAtla, Inc.Listing on record | Buy | $6M | conv 32First in 12mo | SEC | |
BioAtla, Inc.Listing on record | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |